JOWELL GLOBAL LTD (JWEL)

KYG5194C1197 - Common Stock

1.35  -0.03 (-2.17%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to JWEL. JWEL was compared to 124 industry peers in the Specialty Retail industry. While JWEL seems to be doing ok healthwise, there are quite some concerns on its profitability. JWEL does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

JWEL had negative earnings in the past year.
JWEL had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: JWEL reported negative net income in multiple years.
In the past 5 years JWEL reported 4 times negative operating cash flow.

1.2 Ratios

JWEL's Return On Assets of -32.49% is on the low side compared to the rest of the industry. JWEL is outperformed by 90.98% of its industry peers.
Looking at the Return On Equity, with a value of -45.50%, JWEL is doing worse than 68.03% of the companies in the same industry.
Industry RankSector Rank
ROA -32.49%
ROE -45.5%
ROIC N/A
ROA(3y)-19.85%
ROA(5y)-7.65%
ROE(3y)-30.78%
ROE(5y)-9.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 2.04%, JWEL is not doing good in the industry: 96.72% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of JWEL has declined.
JWEL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-42.65%
GM growth 5Y-34.16%

6

2. Health

2.1 Basic Checks

JWEL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JWEL has been increased compared to 1 year ago.
Compared to 5 years ago, JWEL has more shares outstanding
Compared to 1 year ago, JWEL has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.27 indicates that JWEL is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.27, JWEL is doing good in the industry, outperforming 70.49% of the companies in the same industry.
JWEL has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, JWEL is in the better half of the industry, outperforming 72.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 3.27
ROIC/WACCN/A
WACC7.9%

2.3 Liquidity

JWEL has a Current Ratio of 2.95. This indicates that JWEL is financially healthy and has no problem in meeting its short term obligations.
JWEL's Current ratio of 2.95 is amongst the best of the industry. JWEL outperforms 92.62% of its industry peers.
A Quick Ratio of 2.04 indicates that JWEL has no problem at all paying its short term obligations.
JWEL's Quick ratio of 2.04 is amongst the best of the industry. JWEL outperforms 88.52% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.04

3

3. Growth

3.1 Past

JWEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.91%, which is quite good.
JWEL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.81%.
JWEL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.90% yearly.
EPS 1Y (TTM)16.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.55%
Revenue 1Y (TTM)-23.81%
Revenue growth 3Y18.2%
Revenue growth 5Y45.9%
Sales Q2Q%-31.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JWEL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for JWEL!.
Industry RankSector Rank
Dividend Yield N/A

JOWELL GLOBAL LTD

NASDAQ:JWEL (9/27/2024, 8:02:50 PM)

1.35

-0.03 (-2.17%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.93M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.49%
ROE -45.5%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 2.04%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover4.53
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.95
Quick Ratio 2.04
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)16.91%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-23.81%
Revenue growth 3Y18.2%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y